Modulation of the G2 cell cycle checkpoint by sesquiterpene lactones psilostachyins A and C isolated from the common ragweed Ambrosia artemisiifolia

Planta Medica

Volumn 71, Issue 10, 2005, Pages 938-943

  Sturgeon, Christopher M ^a   Craig, Kyle ^a   Brown, Colleen ^a   Rundle, Natalie T ^a   Andersen, Raymond J ^a   Roberge, Michel ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Ambrosia artemisiifolia; Cancer; Cell cycle; Checkpoint; G2 phase; Mitosis

Indexed keywords

AMBROSIA ARTEMISIIFOLIA EXTRACT; CARBONYL DERIVATIVE; ISOPAULITIN; METHANOL DERIVATIVE; PAULITIN; PSILOSTACHYIN A; PSILOSTACHYIN B; PSILOSTACHYIN C; SESQUITERPENE LACTONE DERIVATIVE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; PLANT EXTRACT; SESQUITERPENE;

ARTICLE; ASSAY; CELL CYCLE G2 PHASE; CONTROLLED STUDY; COVALENT BOND; DNA DAMAGE; DRUG ACTIVITY; DRUG ISOLATION; DRUG STRUCTURE; FRACTIONATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MICHAEL ADDITION; MICROTUBULE ASSEMBLY; MITOSIS INHIBITION; PHENOTYPE; RAGWEED; STRUCTURE ACTIVITY RELATION; CELL CYCLE; DOSE RESPONSE; DRUG EFFECT; MITOSIS; PHYTOTHERAPY; TUMOR CELL LINE;

AMBROSIA; AMBROSIA ARTEMISIIFOLIA;

AMBROSIA; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL CYCLE; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; G2 PHASE; HUMANS; MITOSIS; PHYTOTHERAPY; PLANT EXTRACTS; SESQUITERPENES;

EID: 27844495195     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-873109     Document Type: Article

References (30)

1. Sancar A, Lindsey-Bolt LA, Unsal-Kacmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 2004; 73: 39-85
2. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991; 51: 6304-11
3. Kawabe T. G2 checkpoint abrogators as anticancer drugs. Mol Cancer Ther 2004; 3: 513-9
4. Prudhomme M. Combining DNA damaging agents and checkpoint 1 inhibitors. Curr Med Chem Anti-Canc Agents 2004; 4: 435-8
5. Anderson HJ, Andersen RJ, Roberge M. Inhibitors of the G2 DNA damage checkpoint and their potential for cancer therapy. Prog Cell Cycle Res 2003; 5: 423-30
6. Sarkaria JN, Busby EC, Tibbetts RS, Roos P, Taya Y, Karnitz LM et al. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res 1999; 59: 4375-82
7. Zhou BBS, Chaturvedi P, Spring K, Scott SP, Johanson RA, Mishra R et al. Caffeine abolishes the mammalian G2/M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity. J Biol Chem 2000; 275: 10342-8
8. Graves PR, Yu L, Schwarz JK, Gales J, Sausville EA, O'Connor PM et al. The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01. J Biol Chem 2000; 275: 5600-5
9. Yu Q, Rose JL, Zhang H, Takemura H, Kohn KW, Pommier Y. UCN-01 inhibits p53 up-regulation and abrogates gamma-radiation-induced G2-M checkpoint independently of p53 by targeting both of the checkpoint kinases, Chk2 and Chk1. Cancer Res 2002; 62: 5743-8
10. Jiang X, Zhao B, Britton R, Lim LY, Leong D, Sanghera J et al. Inhibition of Chk1 by the G2 DNA damage checkpoint inhibitor isogranulatimide. Mol Cancer Ther 2004; 3: 1221-7
11. Curman D, Cinel B, Williams DE, Rundle N, Block WD, Goodarzi AA et al. Inhibition of the G2 DNA damage checkpoint and of protein kinases Chk1 and Chk2 by the marine sponge alkaloid debromohymenialdisine. J Biol Chem 2001; 276: 17914-9
12. Roberge M, Berlinck RGS, Xu L, Anderson HJ, Lim LY, Curman D et al. High-throughput assay for G2 checkpoint inhibitors and identification of the structurally novel compound isogranulatimide. Cancer Res 1998; 58: 5701-6
13. Budesínsky M, Saman D. Carbon-13 NMR spectra of sesquiterpene lactones. In: Webb GA, editor. Ann Rep NMR Spectrosc, Vol. 30. San Diego: Academic Press; 1995. p. 231-475.
14. Oberti JC, Silva GL, Sosa VE, Kulanthaivel P, Herz W. Ambrosanolides and secoambrosanolides from Ambrosia tenuifolia. Phytochemistry 1986; 25: 1355-8
15. Rodriguez JG, Perales A. Molecular structure and absolute configuration of 2,3-didehydro-1,10-epoxypsilostachyin B (isopaulitin). J Nat Prod 1995; 58: 564-9
16. Borges-del-Castillo J, Manresa-Ferrero MT, Rodriguez-Luis F, Vazquez-Bueno P, Joseph-Nathan P. Carbon-13 NMR study of psilostachyinolides from some Ambrosia species. Org Magn Reson 1981; 17: 232-4
17. Mabry TJ, Miller HE, Kagan HB, Renold W. The structure of psilostachyin, a new sesquiterpene dilactone from Ambroisia psilostachya. Tetrahedron 1966; 22: 1139-46
18. Mabry TJ, Kagan HB, Miller HE. Psilostachyin B, a new sesquiterpene dilactone from Ambrosia psilostachya DC. Tetrahedron 1966; 22: 1943-8
19. Kagan HB, Miller HE, Renold W, Lakshmikantham MV, Tether LR, Herz W et al. The structure of psilostachyin C, a new sesquiterpene dilactone from Ambrosia psilostachya DC. J Org Chem 1966; 31: 1629-32
20. Lee IS, Shamon LA, Chai HB, Chagedera TE, Besterman JM, Farnsworth NR et al. Cell-cycle specific cytotoxicity mediated by rearranged entkaurene diterpenoids isolated from Parinari curatellifolia. Chem Biol Interact 1996; 99: 193-204
21. Rundle NT, Xu L, Andersen RJ, Roberge M. G2 DNA damage checkpoint inhibition and antimitotic activity of 13-hydroxy-15-oxozoapatlin. J Biol Chem 2001; 276: 48 231-6
22. Hadfield JA, Ducki S, Hirst N, McGown AT. Tubulin and microtubules as targets for anticancer drugs. Prog Cell Cycle Res 2003; 5: 309-25
23. Bocca C, Gabriel L, Bozzo F, Miglietta A. A sesquiterpene lactone, costunolide, interacts with microtubule protein and inhibits the growth of MCF-7 cells. Chem Biol Interact 2004; 147: 79-86
24. Miglietta A, Bozzo F, Gabriel L, Bocca C. Microtubule-interfering activity of parthenolide. Chem Biol Interact 2004; 149: 165-73
25. Powell DN, DeFrank JS, Connell P, Eogan M, Preffer F, Dombkowski D et al. Differential sensitivity of p53(-) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay. Cancer Res 1995; 55: 1643-8
26. Russell KJ, Wiens LW, Demers GW, Galloway DA, Plon SE, Groudine M. Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint-competent cells. Cancer Res 1995; 55: 1639-42
27. Fan S, Smith ML 2nd, DJR, Duba D, Zhan Q, Kohn KW et al. Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Res 1995; 55: 1649-54
28. Wang Q, Fan S, Eastman A, Worland PJ, Sausville EA, O'Connor PM. UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53. J Natl Cancer Inst 1996; 88: 956-65
29. Jiang X, Lim LY, Daly JW, Li AH, Jacobson KA, Roberge M. Structure-activity relationships for G2 checkpoint inhibition by caffeine analogs. Int J Oncol 2000; 16: 971-8
30. Braca A, Armenise A, Morelli I, Mendez J, Mi Q, Chai HB et al. Structure of kaurane-type diterpenes from Parinari sprucei and their potential anticancer activity. Planta Med 2004; 70: 540-50